Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tauvid PET in PSP, CBD, and Healthy Volunteers
NCT02167594Phase 1Completed
- Sponsor
- Avid Radiopharmaceuticals
- Start
- Aug 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of flortaucipir in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) (3 arms), sponsored by Avid Radiopharmaceuticals. Primary endpoint: Flortaucipir Imaging in PSP, CBD and Healthy Volunteers at 9 months. Started Aug 2014; status: completed.
02
Drugs
flortaucipir
03
Conditions
progressive supranuclear palsy (PSP)corticobasal degeneration (CBD)
Beyond the preview
Go deeper on NCT02167594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02167594.